FDA PULLS J&J Covid Vaccine! Citing 'Rare Blood Clots'

Vaxxtards won’t ever believe they were poisoned, even if half their family already died from it and it said so on the TV during prime time. No, they will go down with the ship and try to take as many other people as they can with them.

Regarding the j&j vaxx specifically, I do t think it’s been around for a long time. Early on it was pulled by the fda for blood clot events with young people, but then returned quickly to the market for while before going away again to get people to take boosters instead. I remember Trump saying it should not have been pulled for clots because it slowed down the vaxxing of the populace. I have no idea why he didn’t have more compassion for the vaxx injured. It’s still a mystery.

that's the first rule of life. Don't let people who you know are lying to you about what's in the vaccine inject you with a vaccine.

Fake and misleading. It’s not because of “blood clots” and FDA did not cite that in their announcement.

Read the actual FDA letter.

Janssen Biotech, Inc.
Attention: Ms. Ruta Walawalkar
920 Route 202
Raritan, NJ 08869
Re: Revocation of EUA 27205 - Janssen COVID-19 Vaccine

Dear Ms. Walawalkar:

This letter is in response to the request from Janssen Biotech, Inc. received on May 22, 2023, that the U.S. Food and Drug Administration (FDA) withdraw the EUA for the Janssen COVID-19 Vaccine issued on February 27, 2021, as subsequently amended. Janssen Biotech, Inc has informed the FDA that the last lots of the Janssen COVID-19 Vaccine purchased by the United States Government have expired, that there is no demand for new lots of the Janssen COVID-19 Vaccine in the United States, and that Janssen Biotech, Inc does not intend to update the strain composition of this vaccine to address emerging variants.

[link to www.fda.gov (secure)]

Fake and misleading. It’s not because of “blood clots” and FDA did not cite that in their announcement.

Read the actual FDA letter.

Janssen Biotech, Inc.
Attention: Ms. Ruta Walawalkar
920 Route 202
Raritan, NJ 08869
Re: Revocation of EUA 27205 - Janssen COVID-19 Vaccine

Dear Ms. Walawalkar:

This letter is in response to the request from Janssen Biotech, Inc. received on May 22, 2023, that the U.S. Food and Drug Administration (FDA) withdraw the EUA for the Janssen COVID-19 Vaccine issued on February 27, 2021, as subsequently amended. Janssen Biotech, Inc has informed the FDA that the last lots of the Janssen COVID-19 Vaccine purchased by the United States Government have expired, that there is no demand for new lots of the Janssen COVID-19 Vaccine in the United States, and that Janssen Biotech, Inc does not intend to update the strain composition of this vaccine to address emerging variants.

[link to www.fda.gov (secure)]

Fake and misleading. It’s not because of “blood clots” and FDA did not cite that in their announcement.

Read the actual FDA letter.

Janssen Biotech, Inc.
Attention: Ms. Ruta Walawalkar
920 Route 202
Raritan, NJ 08869
Re: Revocation of EUA 27205 - Janssen COVID-19 Vaccine

Dear Ms. Walawalkar:

This letter is in response to the request from Janssen Biotech, Inc. received on May 22, 2023, that the U.S. Food and Drug Administration (FDA) withdraw the EUA for the Janssen COVID-19 Vaccine issued on February 27, 2021, as subsequently amended. Janssen Biotech, Inc has informed the FDA that the last lots of the Janssen COVID-19 Vaccine purchased by the United States Government have expired, that there is no demand for new lots of the Janssen COVID-19 Vaccine in the United States, and that Janssen Biotech, Inc does not intend to update the strain composition of this vaccine to address emerging variants.

[link to www.fda.gov (secure)]

The Food and Drug Administration (FDA) has revoked authorization of Johnson & Johnson’s Covid vaccine after it was paused over rare blood clot concerns, which sent demand plummeting.

The move was not unexpected because J&J’s parent company Jannsen had requested that federal regulators at the FDA withdraw authorization for its vaccine after it was revealed that the last tranche of doses – about 12.5 million – had expired.

[link to www.dailymail.co.uk (secure)]

Rare? They mean "raring to go" blood clots.